ConjuChem Biotechnologies announces filing of patent reexamination request in U.S. Patent & Trademark Office (CNW Group via Yahoo! Finance)

ConjuChem Biotechnologies announces filing of patent reexamination request in U.S. Patent & Trademark Office (CNW Group via Yahoo! Finance)
ConjuChem Biotechnologies Inc. announced today that it has submitted an inter partes request to the U.S. Patent & Trademark Office for reexamination of Patent No. 6,924,264. The patent, entitled “Modified Exendins and Exendin Agonists”, was issued in August 2005 and is assigned to Amylin Pharmaceuticals, Inc.